Table 4.
Clinical trial for the use of SAHA in oncology patients.
| ClinicalTrials.gov Identifier | Status | Conditions | Last Update |
Available Results | Phase |
|---|---|---|---|---|---|
| NCT00735826 | Completed | Aerodigestive Tract Cancer, Lung Cancer, Esophageal Cancer, Head and Neck Cancer (HNSCC) |
12 October 2018 | No | NA |
| NCT02538510 | Completed | HNSCC, Squamous Cell Carcinoma, Nasopharynx Carcinoma, Salivary Gland Carcinoma |
13 September 2022 | Yes [87] | I–II |
| NCT00616967 | Active, Not Recruiting |
Breast Cancer | 3 February 2022 | Yes [88] | II |
| NCT01153672 | Completed | Breast Cancer | 6 September 2019 | Yes [https://clinicaltrials.gov/ct2/show/NCT01153672 accessed on 2 October 2022] | NA |
| NCT00967057 | Completed | Leukemia | 12 August 2013 | Yes [89,90] | III |
| NCT00121225 | Completed | Melanoma | 29 January 2019 | Yes [91] | II |
| NCT00948688 | Terminated | Pancreatic Cancer | 10 May 2017 | No | I–II |
| NCT01075113 | Completed | Liver Cancer | 20 August 2019 | Yes [92] | I |
| NCT02042989 | Completed | Advanced Cancers with MUTp53 | 11 July 2022 | No | I |
| NCT01738646 | Completed | Glioblastoma | 6 March 2017 | Yes [93] | II |
NA—not applicable.